Serum uric acid: a mediator of cardio-reno-metabolic diseases-Reference-Cited by-同舟云学术

Serum uric acid: a mediator of cardio-reno-metabolic diseases

Published:2021-12-02 Issue:12 Volume:19 Page:1127-1128
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Katsiki Niki¹,Athyros Vasilios²

Affiliation:

1. First Department of Internal Medicine, Division of Endocrinology and Metabolism, Diabetes Center, Medical School, AHEPA University Hospital, Thessaloniki, Greece

2. Second Propedeutic Department of Internal Medicine, Medical School, Hippocration Hospital, Thessaloniki, Greece

Funder

Deutsche Forschungsgemeinschaft

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2021.2021071

Reference15 articles.

1. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights

2. Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?

3. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study

4. Non-alcoholic fatty liver disease and dyslipidemia: An update

5. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout in patients with type 2 diabetes mellitus: A propensity‐score‐matched, new‐user design study with an active comparator using the IQVIA Medical Research Data UK database;Diabetes, Obesity and Metabolism;2022-09-20

2. Ganoderma lucidumpolysaccharide peptide alleviates hyperuricemia by regulating adenosine deaminase and urate transporters;Food & Function;2022